 Connection
Eric Poeschla to Genetic Therapy
This is a "connection" page, showing publications Eric Poeschla has written about Genetic Therapy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.482 |
|
|
|
-
Barraza RA, McLaren JW, Poeschla EM. Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure. Mol Ther. 2010 Mar; 18(3):491-501.
Score: 0.284
-
Barraza RA, Poeschla EM. Human gene therapy vectors derived from feline lentiviruses. Vet Immunol Immunopathol. 2008 May 15; 123(1-2):23-31.
Score: 0.250
-
Loewen N, Leske DA, Chen Y, Teo WL, Saenz DT, Peretz M, Holmes JM, Poeschla EM. Comparison of wild-type and class I integrase mutant-FIV vectors in retina demonstrates sustained expression of integrated transgenes in retinal pigment epithelium. J Gene Med. 2003 Dec; 5(12):1009-17.
Score: 0.187
-
Poeschla EM. Non-primate lentiviral vectors. Curr Opin Mol Ther. 2003 Oct; 5(5):529-40.
Score: 0.185
-
Poeschla E, Corbeau P, Wong-Staal F. Development of HIV vectors for anti-HIV gene therapy. Proc Natl Acad Sci U S A. 1996 Oct 15; 93(21):11395-9.
Score: 0.114
-
Poeschla EM, Wong-Staal F. Gene therapy and HIV disease. AIDS Clin Rev. 1995-1996; 1-45.
Score: 0.101
-
Poeschla E, Wong-Staal F. Antiviral and anticancer ribozymes. Curr Opin Oncol. 1994 Nov; 6(6):601-6.
Score: 0.100
-
Barraza RA, Rasmussen CA, Loewen N, Cameron JD, Gabelt BT, Teo WL, Kaufman PL, Poeschla EM. Prolonged transgene expression with lentiviral vectors in the aqueous humor outflow pathway of nonhuman primates. Hum Gene Ther. 2009 Mar; 20(3):191-200.
Score: 0.067
-
Poeschla EM. Integrase, LEDGF/p75 and HIV replication. Cell Mol Life Sci. 2008 May; 65(9):1403-24.
Score: 0.064
-
Loewen N, Poeschla EM. Lentiviral vectors. Adv Biochem Eng Biotechnol. 2005; 99:169-91.
Score: 0.051
-
Wong-Staal F, Poeschla EM, Looney DJ. A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA. Hum Gene Ther. 1998 Nov 01; 9(16):2407-25.
Score: 0.033
-
Yu M, Poeschla E, Wong-Staal F. Progress towards gene therapy for HIV infection. Gene Ther. 1994 Jan; 1(1):13-26.
Score: 0.024
-
Boisgerault N, Kottke T, Pulido J, Thompson J, Diaz RM, Rommelfanger-Konkol D, Embry A, Saenz D, Poeschla E, Pandha H, Harrington K, Melcher A, Selby P, Vile R. Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse. Mol Ther. 2013 Aug; 21(8):1507-16.
Score: 0.023
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|